期刊文献+

肝硬化对乙肝相关性肝癌根治术预后的影响 被引量:12

Relationship between liver cirrhosis and prognosis of HBV-related hepatocellular carcinoma
下载PDF
导出
摘要 目的分析肝硬化与乙肝相关性肝癌预后的关系。方法回顾性分析2005~2012年收治的166例乙肝相关肝癌患者,所有患者已行肝切除术。男性134例,女性32例;年龄32~73岁;其中无肝硬化25例;小结节肝硬化(肝硬化结节≤3 mm)61例;大结节肝硬化(肝硬化结节>3 mm)80例。比较3组患者肝切除术后复发率及总生存率。结果无肝硬化、肝硬化小结节及肝硬化大结节组患者术后复发率及总生存率比较,差异有统计学意义(P<0.05),无肝硬化组患者术后复发率及总生存率优于肝硬化小结节及大结节组患者。肝硬化小结节组和肝硬化大结节组患者术后复发率及总生存率比较,差异无统计学意义(P>0.05)。结论乙肝相关性肝癌患者中,无肝硬化肝癌患者肝切除术后复发率及总生存率优于肝硬化的肝癌患者。 Objective To investigate the relationship between liver cirrhosis and prognosis of HBV-related hepatocellular carcinoma(HCC).Methods The clinical data of166patients with HBV-related HCC from2005to2012were retrospectively reviewed.All patients received liver resection for the treatment of HCC.Among them,134were male and32were female.The patients’age was within a range of32-73years at the time of diagnosis.Of the166patients,25did not have liver cirrhosis,61had liver cirrhosis with small nodules(≤3mm),80had liver cirrhosis with big nodules(>3mm).The recurrence rate(RR)and overall survival(OS)were analyzed and compared among the three groups.Results There were significant differences in RR and OS among the three groups(P<0.05),and the HCC patients without liver cirrhosis had better RR and OS than the HCC patients with liver cirrhosis,while the differences of RR and OS were not significant between the HCC patients with small-nodule liver cirrhosis and those with big-nodule liver cirrhosis(P>0.05).Conclusions HCC patients without liver cirrhosis have better RR and OS than those with liver cirrhosis.
作者 朱海涛 孙诚谊 Hai-tao Zhu;Cheng-yi Sun(Department of Hepatobiliary Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang,Guizhou 550001, China)
出处 《中国现代医学杂志》 CAS 2018年第2期57-60,共4页 China Journal of Modern Medicine
基金 贵州省科技计划项目[No:黔科合LH字(2016)7232号] 贵州省科学技术基金[No:黔科合J字(2014)2015号]
关键词 肝细胞癌 乙型肝炎 肝硬化 hepatocellular carcinoma hepatitis B liver cirrhosis
  • 相关文献

参考文献3

二级参考文献188

  • 1Axel M Gressner,Birgit Lahme,Steffen K Meurer,Olav Gressner,Raif Weiskirchen.Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells[J].World Journal of Gastroenterology,2006,12(5):731-738. 被引量:2
  • 2Patrick Marcellin,Ferruccio Bonino,Cihan Yurdaydin,Stephanos Hadziyannis,Rami Moucari,Hans-Peter Kapprell,Vivien Rothe,Matei Popescu,Maurizia R. Brunetto.Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients[J]. Hepatology International . 2013 (1)
  • 3Feng Xia,Eric Lai,Wan-Yee Lau,Kuansheng Ma,Xiaowu Li,Ping Bie,Cheng Qian.High Serum Hyaluronic Acid and HBV Viral Load are Main Prognostic Factors of Local Recurrence after Complete Radiofrequency Ablation of Hepatitis B-Related Small Hepatocellular Carcinoma[J]. Annals of Surgical Oncology . 2012 (4)
  • 4Tai–Chung Tseng,Chun–Jen Liu,Hung–Chih Yang,Tung–Hung Su,Chia–Chi Wang,Chi–Ling Chen,Stephanie Fang–Tzu Kuo,Chen–Hua Liu,Pei–Jer Chen,Ding–Shinn Chen,Jia–Horng Kao.High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load[J]. Gastroenterology . 2012 (5)
  • 5Hidenori Toyoda,Takashi Kumada,Toshifumi Tada,Yasuhiro Sone,Masashi Fujimori.Transarterial Chemoembolization for Hepatitis B Virus–associated Hepatocellular Carcinoma: Improved Survival after Concomitant Treatment with Nucleoside Analogues[J]. Journal of Vascular and Interventional Radiology . 2012 (3)
  • 6Li-Tzong Chen,Miin-Fu Chen,Lung-An Li,Po-Huang Lee,Long-Bin Jeng,Deng-Yn Lin,Cheng-Chung Wu,King-Tong Mok,Chao-Long Chen,Wei-Chen Lee,Gar-Yang Chau,Yaw-Sen Chen,Wing-Yui Lui,Chin-Fu Hsiao,Jacqueline Whang-Peng,Pei-Jer Chen.Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection[J]. Annals of Surgery . 2012 (1)
  • 7TetsuyaHosaka,FumitakaSuzuki,MasahiroKobayashi,MiharuHirakawa,YusukeKawamura,HiromiYatsuji,HitomiSezaki,NorioAkuta,YoshiyukiSuzuki,SatoshiSaitoh,YasujiArase,KenjiIkeda,MarikoKobayashi,HiromitsuKumada.HBcrAg is a predictor of post‐treatment recurrence of hepatocellular carcinoma during antiviral therapy[J]. Liver International . 2010 (10)
  • 8Nan Li MD,Eric C. H. Lai MBChB, MRCS(Ed), FRACS,Jie Shi MD,Wei-Xing Guo MD,Jie Xue MD,Bing Huang MD,Wan-Yee Lau MD, FRCS, FACS, FRACS(Hon),Meng-Chao Wu MD,Shu-Qun Cheng MD.A Comparative Study of Antiviral Therapy After Resection of Hepatocellular Carcinoma in the Immune-Active Phase of Hepatitis B Virus Infection[J]. Annals of Surgical Oncology . 2010 (1)
  • 9Makoto Chuma,Shuhei Hige,Toshiya Kamiyama,Takashi Meguro,Atsushi Nagasaka,Kazuaki Nakanishi,Yoshiya Yamamoto,Mitsuru Nakanishi,Toshihisa Kohara,Takuya Sho,Keiko Yamamoto,Hiromasa Horimoto,Tomoe Kobayashi,Hideki Yokoo,Michiaki Matsushita,Satoru Todo,Masahiro Asaka.The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma[J]. Journal of Gastroenterology . 2009 (9)
  • 10George N. Ioannou,James D. Perkins,Robert L. Carithers.Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival[J]. Gastroenterology . 2008 (5)

共引文献55

同被引文献143

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部